Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) shares opened the most recent trading session at 258.460 and at the time of writing the last Bid was at 270.322. In the current trading session the stock reached as high as 272.350 and dipped down to 258.460. Intercept Pharmaceuticals, Inc., a NMS listed company, has a current market cap of 6.51B and on average over the past 3 months has seen 474722 shares trade hands on a daily basis.
On a technical level the stock has a 50 Day Moving Average of 249.950. Based on a recent trade, this puts the equity at +8.150% away from that average. In comparing the stock’s current level to its extended history, the stock is trading -22.562% away from its 52-week high of 349.080 and +110.367% away from the stock’s low point over the past 52 weeks, which was 128.500.
There are a number of Wall Street research brokerages which cover the stock and offer projections on earnings and future stock movement. On a consensus basis, analysts have a one year target price of 409.000. The company’s trailing twelve month (ttm) EPS stands at -3.570. The consensus analyst estimates according to First Call for the next quarter is -2.230. The current year EPS estimate on the stock is -8.490 and the EPS estimate for next year sits at -8.410.
The price to earnings ratio, or the valuation ratio of a company’s current share price compared to its per-share earnings sits at N/A. This is an important indicator as a higher ratio typically suggests that investors are expecting higher future earnings growth compared to companies in the same industry with lower price to earnings ratios. When calculating in the EPS estimates for the current year from sell-side analysts, the Price to current year EPS stands at N/A. Investors looking further ahead, will note that the Price to next year’s EPS is N/A.